A bill to allow for the establishment of a wholesale prescription drug importation program; to provide for the powers and duties of certain state and local governmental officers and entities; and to allow for the promulgation of rules.
This initiative seeks to ensure the importation of safe, effective prescription drugs from Canada, adhering to U.S. safety and cost-saving standards. The program involves contracting with licensed drug wholesalers and mandates compliance with tracking, tracing, and record-keeping requirements. It prohibits the distribution of imported drugs outside Michigan and requires U.S. Department of Health and Human Services certification before implementation. Additionally, the bill outlines the creation of a public list of imported drugs' wholesale acquisition costs, development of an outreach plan, and annual reporting on the program's operation, including cost savings and audit findings. It also addresses the integration with the federal 340B program to maximize participation without affecting eligibility and mandates consultation with the attorney general to monitor for anti-competitive behavior.
Co-sponsored by Sens.
Referred to the Committee on Health Policy
